Implantable Drug Eluting Devices Market Snapshot (2022 to 2029)

Global Implantable Drug Eluting Devices Market is set to experience significant growth of 6.0% CAGR from 2022 to 2029, with an estimated market value of around USD 12.8 Billion as of 2022. As per Future Market Insights projections, contraceptive drug eluting devices products hold a substantial share of over 39.8% in 2021 within the global market.

Data Points Market Insights
Market Value 2021 USD 12.1 Billion
Market Value 2022 USD 12.8 Billion
Market Value 2029 USD 19.3 Billion
CAGR 2022 to 2029 6.0%
Market Share of Top 5 Countries 76.5%

With the growth in demand for minimally-invasive procedures, implantable drug eluting devices are accumulating a rising range in terms of market penetration, which are established by key market leaders.

Similarly, start-up companies as well as majorly rooted corporations over the globe are working hard to develop novel implantable drug delivery technologies, using a wide range of knowledge available in the network which includes research institutions, universities, teaching hospitals, and companies.

Due to a massive demand for combination products such as drug eluting devices, major players in the market are adopting competitive strategies such as acquisitions, mergers, as well as collaborations for the development and augmentation of products in the market.

How The Market Progressed Till June 2022?

Particulars Details
H1, 2021 6.03%
H1, 2022 Projected 6.00%
H1, 2022 Outlook 5.90%
BPS Change - H1, 2022 (O) – H1, 2022 (P) (-) 10 ↓
BPS Change – H1, 2022 (O) – H1, 2021 (-) 13 ↓

According to Future Market Insights’ analysis, the global implantable drug eluting devices market will observe a diminished change in the Basis Point Share (BPS) by nearly 13 BPS in H1- 2022 (O) as compared with H1-2021. The attribute of non-biodegradable implants, which includes the requirement for surgical removal or the accumulation of polymer in the body after usage, has a negative impact on the total market.

Non-biodegradable implants are generally more traumatic to remove than they are to place. This is based on available clinical studies data. The comparative analysis and market growth rate of the global implantable drug eluting devices market as studied by Future Market Insights will show a negative BPS growth in the H1-2022 outlook as compared to H1-2022 projected period by 10 BPS. Furthermore, the manufacture of implants necessitates the use of huge amounts of organic solvent, which might affect drug stability and toxicity, as well as raise environmental problems.

On the contrary, numerous factors present several benefits to the overall implantable drug eluting devices market, including the adoption of compression as a manufacturing technique for implantable drugs, which refrains from the use of heat or solvents, making it a suitable method for the manufacture of implants containing heat or solvent sensitive compounds such proteins or peptides.

This is set to advance the manufacturing capacities of key producers within the global industry space.

Sales Analysis of Implantable Drug Eluting Devices from 2014 to 2021 Vs Market Outlook for 2022 to 2029

The market value for Implantable Drug Eluting Devices holds nearly 5.8% of the overall USD 208.0 Billion Drug Delivery Devices market in 2021.

Implantable drug eluting devices provide numerous distinctive advantages which include the exceptional prospects of site-specificity, localization, and targeted drug delivery process.

The applications of implantable drug eluting devices are indispensable when considered under the scope of cardiology, ophthalmology, birth control, opioid addiction, pain management, diabetes management, contraception, as well as cancer therapy. The targeted drug delivery systems improve the efficacy of treatment (oncology and cardiology) and assist with the reduction of side effects by preventing damage to healthy tissue.

The implantable drug eluting devices are segmented into two main types: active drug eluting devices and passive drug eluting devices.

The technologies essentially incorporated in the active drug eluting devices are electromechanical and osmotic pressure gradients. Furthermore, the passive drug eluting devices are sub-segmented into 2 types which include biodegradable implants and non-biodegradable implants, wherein, the biodegradable implants are polyester amide and Polylactic glycolic acids devised and the non-biodegradable implantable devices are made using silicon, polyethylene-vinyl acetate, and thermoplastic polyurethane.

The non-biodegradable implants possess wide-ranging applications in diabetes, contraception, hormone regulation, pain management, cancer treatment, etc. Implantable drug delivery devices commonly comprise a drug reservoir enclosed by a polymer or a mixture of a drug-polymer.

The implant, when incorporated into the desired, localized area of the body, releases the drug at a pre-calculated rate whilst the polymer degrades.

The effective drug delivery system through implantable drug eluting devices is thus set to gain traction in terms of adoption over the forecast period, owing to the specificity of the target site and the rate of drug dissolution into the localized area of therapy.

The market is expected to expand at a considerable growth rate over the next seven years at a CAGR of close to 6.0%.

What are the Key Opportunities for Implantable Drug Eluting Devices Manufacturers?

The implantable drug eluting devices is predicted to exhibit lucrative growth over the forecast period. This growth can be associated with the rising adoption of patient-controlled devices and increasing the incidence of peripheral and coronary artery diseases. Additionally, the key market players are displaying extensive focus on clinical trials of bio-reabsorbable stents and implantable drug infusion pumps.

Therefore, the growing adoption by patients and physicians, and rising demand for minimally invasive surgeries are set to offer growth opportunities to key market players in the development of novel implantable drug-eluting devices. Furthermore, the rising incidence of cardiovascular and chronic diseases over the globe is generating growth opportunities for the global implantable drug eluting devices market.

According to the WHO, cardiovascular diseases are one of the major causes of mortality globally.

Several research and clinical studies are currently taking place for the improvement of the functioning of existing drug eluting stents and devices. Research in this area is thus focused on the evaluation and development of novel and augmented drug eluting devices, which uphold notable clinical benefits and eliminate safety concerns regarding their long-term application. The innovative efforts in research on next-generation drug eluting devices are expected to further progress procedures such as endothelialization and rapid arterial healing.

These factors are thus comprehensively set to promote the growth of the implantable drug eluting devices market throughout the forecast period.

What are the Factors Restraining Demand for Implantable Drug Eluting Devices?

The factors associated with risks associated with the limited demand and value growth of the implantable drug eluting devices include the process of product recalls, which are indispensable for public health and safety as it leads to the voluntary action of manufacturers and distributors to carry out their responsibility that presents a risk of injury or defective or gross deception of products.

Additionally, pending approvals of products by regulatory bodies may hinder the growth of injunctions which can restrain the sale of products and may remarkably divert the attention of the management and technical personnel in the market. In the event of approval pending, the company's financial condition, business, and results of operations could be adversely affected. Moreover, several implantable drug eluting devices pose a problem in terms of patient adherence, terms of discomfort upon the implants being incorporated into them.

The ongoing biodegradation of the drug-eluting stents sometimes makes it difficult to maintain the accurate dose at the end of its lifetime. There is always a risk of device failure, which may result in another surgical involvement to correct the device.

Another factor of concern includes the fact that most implants possess an inadequate loading capacity owing to their small size. This gives way to some specific potent medicines for appropriate delivery by implantable devices.

The concerns arising from bodily reaction to a foreign substance also conceive a restrictive growth in the deployment of implants in lieu of its biocompatibility and safety. These factors collectively induce restraint in the growth of the implantable drug eluting devices market, however, augmented and personalized implant designing may prove to enhance the efficacy of the implanted drug delivery process.

Country-wise Insights

What Makes the USA the Largest Market for Implantable Drug Eluting Devices?

The USA dominates the North American region with a total market share of over 94.1% in 2021 and is projected to continue experiencing high growth throughout the forecast period.

The vast majority of shares gained by the USA in the implantable drug eluting devices market are owed to the factors associated with rising disease burden, increasing geriatric population, and the developing healthcare infrastructure which offers reimbursement opportunities for new procedures.

Why is Germany Considered a Lucrative Market for Implantable Drug Eluting Devices in Europe?

Germany is set to exhibit a CAGR of over 6.2% in the European implantable drug eluting devices market during the forecast period. The lucrative growth in the region is associated with the emergence of key and established players in the country, focusing on research and innovative methodologies for drug delivery and targeted site delivery systems.

What Makes China an Emerging Market for Implantable Drug Eluting Devices?

China holds a 46.1% market revenue share in the East Asia market in 2021 and is projected to increase at a CAGR rate of 8.7% during the forecast period. The growth of the implantable drug eluting devices market in the country is attributed to the development of novel drug delivery technologies, such as an implantable nanogenerator, which can be adopted for precise drug delivery systems. Furthermore, increasing government funding for research and development activities is set to augment the China implantable drug eluting devices market over the forecast period.

What is the Outlook for Japan Regarding Implantable Drug Eluting Devices?

In 2021, Japan held a 39.3% share in the East Asia implantable drug eluting devices market and is projected to expand at a CAGR of 8.2% from 2022 to 2029. The growth is associated with the rapid adoption of automated systems in the country, including models for site-specific and targeted drug delivery systems. These augmentations are cost-effective and reduce the error rate during clinical trials.

Category-wise Insights

Which Implantable Drug Eluting Devices Product is Driving Market Growth?

Contraceptive drug eluting devices project lucrative growth at a CAGR of 6.0% till the end of the forecast period, with a market share of around 39.8% in 2021. The growth is associated with the factor of increasing awareness in terms of female and reproductive health over the globe, and the efforts to minimize the mortality and morbidity rate associated with female reproductive health.

Which Technology is Large of Focus in the Implantable Drug Eluting Devices Market?

Passive drug eluting device technology holds a revenue share of 96.2% in 2021 and is projected to hold a share over the forecast period with the estimation being 96.6%. The segment holds the maximum revenue share due to the wide-ranging applications of passive drug eluting devices in the field of oncology, cardiology, pain management, contraception, etc.

Which Application is Large of Focus in the Implantable Drug Eluting Devices Market?

Cardiovascular applications hold a revenue share of 45.1% in 2021 and are projected to hold a share over the forecast period with the estimation being 47.3%. The segment gains traction with the rising incidence of chronic diseases and the risks associated with infectious agents among the geriatric population.

Which Implantation Type Holds a Dominant Stance in the Global Implantable Drug Eluting Devices Market?

Intravascular implantation type holds a revenue share of 44.1% in 2021 and is projected to hold a share over the forecast period with the estimation being 46.1%. The extensive ranging applications of the intravascular implants as well as the efficient patient adherence and outcomes have contributed to this method being implemented widely across several treatment indications.

Which End User Holds a Dominant Stance in the Global Implantable Drug Eluting Devices Market?

Hospitals hold a revenue share of 61.9% in 2021 and are projected to hold a share over the forecast period with the estimation being 66.0%. The process of targeted drug delivery through implantable drug eluting devices requires the aid of skilled physicians with patient data for close monitoring in the event of implant rejection or other adverse events. Thus, the hospital segment accounts for a massive share of the implantable drug eluting devices market.

Competitive Landscape

Corporate tie-ups amongst implantable drug eluting device manufacturers, acquisitions, expansion, product launches, agreements, and increasing clinical trials and research activities are the key strategies adopted by manufacturers to increase product sales in different geographies.

  • In August 2021, Medtronic plc announced that it has entered into a definitive agreement with Intersect ENT a global medical technology leader dedicated to transforming patient care, in which Medtronic will acquire all outstanding shares of Intersect ENT.
  • In March 2020, Allergan received FDA approval for DURYSTA™ (bimatoprost implant) the first and only Intracameral Biodegradable Sustained-Release implant to lower intraocular pressure in Open-Angle Glaucoma or Ocular Hypertension Patients.

Similarly, recent developments related to companies operating in the implantable drug eluting devices market have been tracked by the team at Future Market Insights, which are available in the full report.

Report Scope as per Implantable Drug Eluting Devices Market Analysis

Attribute Details
Forecast Period 2022 to 2029
Historical Data Available for 2014 to 2021
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa
Key Countries Covered USA, Canada, Brazil, Mexico, Argentina, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, GCC Countries, Northern Africa, South Africa, Turkey
Key Market Segments Covered Product, Technology, Application, Implantation Type, End User, and Region
Key Companies Profiled Pfizer Inc.; Medtronic Inc.; Merck & Co., In; Bayer AG; JOHNSON & JOHNSON; SurModics Inc.; AstraZeneca Plc.; Boston Scientific Corporation; Titan Pharmaceuticals, Inc.; BIOTRONIK, INC.; Abbott Laboratories; Allergan, Inc.; Bausch and Lomb, Inc.; Alimera Sciences; REVA Medical, Inc.
Pricing Available upon Request

Key Market Segments Covered in Implantable Drug Eluting Devices Industry Research

By Product:

  • Implantable Drug Infusion Pumps
  • Intraocular Drug Eluting Devices
  • Contraceptive Drug Eluting Devices
  • Buprenorphine Implant
  • Drug Eluting Stents
  • Others

By Technology:

  • Active Drug Eluting Device
  • Passive Drug Eluting Device
    • Biodegradable Implants
    • Non-Biodegradable Implants

By Application:

  • Diabetic Macular Edema
  • Birth Control/Contraception
  • Opioid Addiction
  • Cardiovascular
  • Ophthalmology
  • Oncology
  • Pain Management

By Implementation Type:

  • Intravaginal
  • Intravascular
  • Intraocular
  • Intrathecal
  • Subcutaneous
  • Intrauterine

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Optical Care Centers
  • Cardiac Surgery Centers
  • Office Based Settings
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Key Market Trends
  • 4. Key Success Factors
  • 5. Market Context
  • 6. Global Market Demand Analysis 2014 to 2021 and Forecast, 2022 to 2029
  • 7. Global Market Pricing Analysis
  • 8. Global Market Demand (in Value or Size in USD Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029
  • 9. Market Background
  • 10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Technology
    • 10.1. Active Drug Eluting Device
    • 10.2. Passive Drug Eluting Device
      • 10.2.1. Biodegradable implants
      • 10.2.2. Non-biodegradable implants
  • 11. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product
    • 11.1. Implantable Drug Infusion Pumps
    • 11.2. Intraocular Drug Eluting Devices
    • 11.3. Contraceptive Drug Eluting Devices
    • 11.4. Buprenorphine Implant
    • 11.5. Drug-Eluting Stents
    • 11.6. Others
  • 12. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Application
    • 12.1. Diabetic Macular Edema
    • 12.2. Birth Control/Contraception
    • 12.3. Opioid Addiction
    • 12.4. Cardiovascular
    • 12.5. Ophthalmology
    • 12.6. Oncology
    • 12.7. Pain Management
  • 13. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Implantation Type
    • 13.1. Intravaginal
    • 13.2. Intravascular
    • 13.3. Intraocular
    • 13.4. Intrathecal
    • 13.5. Subcutaneous
    • 13.6. Intrauterine
  • 14. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by End User
    • 14.1. Hospitals
    • 14.2. Ambulatory Surgical Centres
    • 14.3. Optical Care Centres
    • 14.4. Cardiac Surgery Centres
    • 14.5. Office based settings
    • 14.6. Others
  • 15. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region
    • 15.1. North America
    • 15.2. Latin America
    • 15.3. Europe
    • 15.4. Middle East and Africa (MEA)
    • 15.5. East Asia
    • 15.6. South Asia
    • 15.7. Oceania
  • 16. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 17. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 18. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 19. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 20. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 21. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 22. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 23. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
  • 24. Market Structure Analysis
  • 25. Competition Analysis
    • 25.1. Pfizer Inc.
    • 25.2. Medtronic Inc.
    • 25.3. Merck & Co., Inc.
    • 25.4. Bayer AG
    • 25.5. Johnson & Johnson
    • 25.6. SurModics Inc.
    • 25.7. AstraZeneca Plc.
    • 25.8. Boston Scientific Corporation
    • 25.9. Titan Pharmaceuticals, Inc.
    • 25.10. BIOTRONIK, INC.
    • 25.11. Abbott Laboratories
    • 25.12. Allergan, Inc.
    • 25.13. Bausch and Lomb, Inc.
    • 25.14. Alimera Sciences
    • 25.15. REVA Medical, Inc.
  • 26. Assumptions and Acronyms Used
  • 27. Research Methodology

List of Tables

Table 01: Global Market Volume (in Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

Table 02: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

Table 03: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 04: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 05: Global Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 06: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 07: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 08: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 09: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 10: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 11: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 12: North America Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 13: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 14: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 15: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 16: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 17: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 18: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 19: Latin America Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 20: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 21: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 22: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 23: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 24: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 25: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 26: Europe Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 27: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 28: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 29: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 30: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 31: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 32: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 33: East Asia Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 34: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 35: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 36: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 37: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 38: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 39: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 40: South Asia Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 41: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 42: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 43: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 44: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 45: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 46: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 47: Oceania Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 48: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 49: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 50: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 51: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Table 52: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 53: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 54: Middle East and Africa Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 55: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 56: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 57: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 58: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 59: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 60: China Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 61: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 62: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 63: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 64: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 65: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 66: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 67: India Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 68: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 69: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 70: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Table 71: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Table 72: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 73: India Market Size Volume (Units) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Table 74: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Table 75: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Table 76: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

List of Figures

Figure 01: Global Market Value Share, by Product (2022E)

Figure 02: Global Market Value Share, by Technology (2022E)

Figure 03: Global Market Value Share, by Implantation Type (2022E)

Figure 04: Global Market Value Share, by Application (2022E)

Figure 05: Global Market Value Share, by End User (2022E)

Figure 06: Global Market Value Share, by Region (2022E)

Figure 07: Global Market Size (US$ Million) Analysis, 2014 to 2021

Figure 08: Global Market Size (US$ Million) & Y-o-Y Growth (%) Analysis, 2022 to 2029

Figure 09: Global Market Absolute $ Opportunity Analysis, 2022 to 2029

Figure 10: Global Market Volume (in Units) Analysis, 2014 to 2021

Figure 11: Global Market Volume (in Units) & Y-o-Y Growth (%) Analysis, 2022 to 2029

Figure 12: Global Market Analysis by Region –2022 & 2029

Figure 13: Global Market Y-o-Y Growth Projections by Region, 2022 to 2029

Figure 14: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Region

Figure 15: Global Market Analysis by Technology –2022 & 2029

Figure 16: Global Market Y-o-Y Growth Projections by Technology, 2022 to 2029

Figure 17: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 18: Global Market Analysis by Product –2022 & 2029

Figure 19: Global Market Y-o-Y Growth Projections by Product, 2022 to 2029

Figure 20: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 21: Global Market Analysis by Application –2022 & 2029

Figure 22: Global Market Y-o-Y Growth Projections by Application, 2022 to 2029

Figure 23: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 24: Global Market Analysis by Implantation Type –2022 & 2029

Figure 25: Global Market Y-o-Y Growth Projections by Implantation Type, 2022 to 2029

Figure 26: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 27: Global Market Analysis by End User –2022 & 2029

Figure 28: Global Market Y-o-Y Growth Projections by End User, 2022 to 2029

Figure 29: Global Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 30:North America Market Size (US$ Million) Analysis, 2014 to 2021

Figure 31: North America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 32: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 33: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 34: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 35: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 36: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 37: North America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 38:Latin America Market Size (US$ Million) Analysis, 2014 to 2021

Figure 39: Latin America Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 40: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 41: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 42: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 43: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 44: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 45: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 46:Europe Market Size (US$ Million) Analysis, 2014 to 2021

Figure 47: Europe Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 48: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 49: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 50: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 51: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 52: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 53: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 54:East Asia Market Size (US$ Million) Analysis, 2014 to 2021

Figure 55: East Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 56: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 57: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 58: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 59: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 60: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 61: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 62:South Asia Market Size (US$ Million) Analysis, 2014 to 2021

Figure 63: South Asia Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 64: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 65: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 66: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 67: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 68: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 69: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 70:Oceania Market Size (US$ Million) Analysis, 2014 to 2021

Figure 71: Oceania Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 72: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 73: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 74: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 75: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 76: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 77: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 78:Middle East and Africa Market Size (US$ Million) Analysis, 2014 to 2021

Figure 79: Middle East and Africa Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 80: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Country

Figure 81: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 82: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 83: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 84: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 85: Middle East and Africa Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 86:China Market Size (US$ Million) Analysis, 2014 to 2021

Figure 87: China Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 88: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 89: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 90: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 91: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 92: China Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 93:India Market Size (US$ Million) Analysis, 2014 to 2021

Figure 94: India Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 95: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 96: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 97: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 98: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 99: India Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Figure 100:Brazil Market Size (US$ Million) Analysis, 2014 to 2021

Figure 101: Brazil Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029

Figure 102: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Product

Figure 103: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Implantation Type

Figure 104: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Application

Figure 105: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By End User

Figure 106: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Forecast 2022 to 2029, By Technology

Frequently Asked Questions

How much is the Implantable Drug Eluting Devices market currently worth?

The global implantable drug eluting devices market is worth USD 12.1 Billion at present and is set to expand 1.5 X over the next seven years.

What is the sales forecast for Implantable Drug Eluting Devices through 2029?

The implantable drug eluting devices market is expected to reach USD 19.3 Billion by the end of 2029, with sales revenue expected to register 6.0% CAGR.

What are the key trends shaping the Implantable Drug Eluting Devices industry?

Growing research collaborations and distribution of implantable drug eluting devices by key market leaders, new product launches and government initiatives are some of the key trends being witnessed in this marketplace.

Which are the top 5 countries driving demand for Implantable Drug Eluting Devices?

The USA, Germany, the United Kingdom, France, and China are expected to drive demand in the implantable drug eluting devices market.

What is the North America market outlook for Implantable Drug Eluting Devices?

North America is one of the key markets for implantable drug eluting devices, with the USA expected to account for over 95.3% of the North American market during the forecast period.

At what percentage is the demand for Implantable Drug Eluting Devices expected to register growth in Europe?

Demand for implantable drug eluting devices in Europe is expected to register a growth of 4.9% over the next seven years.

Which countries are key producers of Implantable Drug Eluting Devices products?

The USA, United Kingdom, and Germany are key producers of implantable drug eluting device products.

Which are the key exporters of Implantable Drug Eluting Devices market?

Pfizer Inc., Medtronic Inc., Merck & Co. In, Bayer AG, JOHNSON & JOHNSON, SurModics Inc., AstraZeneca Plc., Boston Scientific Corporation, Titan Pharmaceuticals, Inc., BIOTRONIK, INC., Abbott Laboratories, Allergan, Inc., Bausch and Lomb, Inc., Alimera Sciences, and REVA Medical, Inc. are the key exporters of implantable drug eluting devices market.

Explore Similar Insights

Future Market Insights

Implantable Drug Eluting Devices Market